Dohertyet al (1997) (RS)-2-Chloro-5-hydroxyphenylglycine (CHPG)
activates mGlu5, but not mGlu1, receptors expressed in CHO cells and potentiates NMDA responses
in the hippocampus. Neuropharmacology 36 265. Saltet
al (1999) Antagonism of the mGlu5 agonist 2-chloro-5-hydroxyphenylglycine
by the novel selective mGlu5 antagonist 6-methyl-2-(phenylethynyl)-pyridine
(MPEP) in the thalamus. Br.J.Pharmacol. 127 1057. Baoet
al (2001) Selective mGluR5 receptor antagonist or agonist provides
neuroprotection in a rat model of focal cerebral ischaemia. Brain Res. 922
173.